Cargando…

Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics

BACKGROUND: We describe the development and evaluation of a novel method for targeted amplification and Next Generation Sequencing (NGS)-based identification of viral hemorrhagic fever (VHF) agents and assess the feasibility of this approach in diagnostics. METHODOLOGY: An ultrahigh-multiplex panel...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkmann, Annika, Ergünay, Koray, Radonić, Aleksandar, Kocak Tufan, Zeliha, Domingo, Cristina, Nitsche, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714388/
https://www.ncbi.nlm.nih.gov/pubmed/29155823
http://dx.doi.org/10.1371/journal.pntd.0006075
_version_ 1783283576060510208
author Brinkmann, Annika
Ergünay, Koray
Radonić, Aleksandar
Kocak Tufan, Zeliha
Domingo, Cristina
Nitsche, Andreas
author_facet Brinkmann, Annika
Ergünay, Koray
Radonić, Aleksandar
Kocak Tufan, Zeliha
Domingo, Cristina
Nitsche, Andreas
author_sort Brinkmann, Annika
collection PubMed
description BACKGROUND: We describe the development and evaluation of a novel method for targeted amplification and Next Generation Sequencing (NGS)-based identification of viral hemorrhagic fever (VHF) agents and assess the feasibility of this approach in diagnostics. METHODOLOGY: An ultrahigh-multiplex panel was designed with primers to amplify all known variants of VHF-associated viruses and relevant controls. The performance of the panel was evaluated via serially quantified nucleic acids from Yellow fever virus, Rift Valley fever virus, Crimean-Congo hemorrhagic fever (CCHF) virus, Ebola virus, Junin virus and Chikungunya virus in a semiconductor-based sequencing platform. A comparison of direct NGS and targeted amplification-NGS was performed. The panel was further tested via a real-time nanopore sequencing-based platform, using clinical specimens from CCHF patients. PRINCIPAL FINDINGS: The multiplex primer panel comprises two pools of 285 and 256 primer pairs for the identification of 46 virus species causing hemorrhagic fevers, encompassing 6,130 genetic variants of the strains involved. In silico validation revealed that the panel detected over 97% of all known genetic variants of the targeted virus species. High levels of specificity and sensitivity were observed for the tested virus strains. Targeted amplification ensured viral read detection in specimens with the lowest virus concentration (1–10 genome equivalents) and enabled significant increases in specific reads over background for all viruses investigated. In clinical specimens, the panel enabled detection of the causative agent and its characterization within 10 minutes of sequencing, with sample-to-result time of less than 3.5 hours. CONCLUSIONS: Virus enrichment via targeted amplification followed by NGS is an applicable strategy for the diagnosis of VHFs which can be adapted for high-throughput or nanopore sequencing platforms and employed for surveillance or outbreak monitoring.
format Online
Article
Text
id pubmed-5714388
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57143882017-12-15 Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics Brinkmann, Annika Ergünay, Koray Radonić, Aleksandar Kocak Tufan, Zeliha Domingo, Cristina Nitsche, Andreas PLoS Negl Trop Dis Research Article BACKGROUND: We describe the development and evaluation of a novel method for targeted amplification and Next Generation Sequencing (NGS)-based identification of viral hemorrhagic fever (VHF) agents and assess the feasibility of this approach in diagnostics. METHODOLOGY: An ultrahigh-multiplex panel was designed with primers to amplify all known variants of VHF-associated viruses and relevant controls. The performance of the panel was evaluated via serially quantified nucleic acids from Yellow fever virus, Rift Valley fever virus, Crimean-Congo hemorrhagic fever (CCHF) virus, Ebola virus, Junin virus and Chikungunya virus in a semiconductor-based sequencing platform. A comparison of direct NGS and targeted amplification-NGS was performed. The panel was further tested via a real-time nanopore sequencing-based platform, using clinical specimens from CCHF patients. PRINCIPAL FINDINGS: The multiplex primer panel comprises two pools of 285 and 256 primer pairs for the identification of 46 virus species causing hemorrhagic fevers, encompassing 6,130 genetic variants of the strains involved. In silico validation revealed that the panel detected over 97% of all known genetic variants of the targeted virus species. High levels of specificity and sensitivity were observed for the tested virus strains. Targeted amplification ensured viral read detection in specimens with the lowest virus concentration (1–10 genome equivalents) and enabled significant increases in specific reads over background for all viruses investigated. In clinical specimens, the panel enabled detection of the causative agent and its characterization within 10 minutes of sequencing, with sample-to-result time of less than 3.5 hours. CONCLUSIONS: Virus enrichment via targeted amplification followed by NGS is an applicable strategy for the diagnosis of VHFs which can be adapted for high-throughput or nanopore sequencing platforms and employed for surveillance or outbreak monitoring. Public Library of Science 2017-11-20 /pmc/articles/PMC5714388/ /pubmed/29155823 http://dx.doi.org/10.1371/journal.pntd.0006075 Text en © 2017 Brinkmann et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Brinkmann, Annika
Ergünay, Koray
Radonić, Aleksandar
Kocak Tufan, Zeliha
Domingo, Cristina
Nitsche, Andreas
Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title_full Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title_fullStr Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title_full_unstemmed Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title_short Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
title_sort development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714388/
https://www.ncbi.nlm.nih.gov/pubmed/29155823
http://dx.doi.org/10.1371/journal.pntd.0006075
work_keys_str_mv AT brinkmannannika developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics
AT ergunaykoray developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics
AT radonicaleksandar developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics
AT kocaktufanzeliha developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics
AT domingocristina developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics
AT nitscheandreas developmentandpreliminaryevaluationofamultiplexedamplificationandnextgenerationsequencingmethodforviralhemorrhagicfeverdiagnostics